Catalyst Repository | Vincerx Pharma Inc. Common Stock

Vincerx Pharma Inc. Common Stock

(NASDAQ:VINC)

Description

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops new therapies to address unmet medical needs for the treatment of cancer. The company's lead product candidate is VIP152 that is in clinical trials. Its drug candidates are in development for the treatment of solid tumors, leukemia, B-cell malignancies, lymphomas, and myelodysplastic syndrome. Vincerx Pharma, Inc. is based in Palo Alto, California.

VINC Overview

None
Sector
Health Care
Industry
Major Pharmaceuticals

Previous Close
$1.3500
Previous Close Volume
18780